Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Randomized Phase II Trial of Timed Sequential Cytosine Arabinoside (Ara-C) With and Without the Checkpoint Kinase 1 (CHK1) Inhibitor MK-8776 in Adults With Relapsed AML

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01870596
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:07.660613+00:00
Published At
2016-09-01T00:00:00+00:00
Record Updated At
2016-09-01
Results Posted At
2016-09-01
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Adult Acute Megakaryoblastic Leukemia", "Adult Acute Monoblastic Leukemia", "Adult Acute Monocytic Leukemia", "Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11", "Adult Acute Myeloid Leukemia With Maturation", "Adult Acute Myeloid Leukemia With Minimal Differentiation", "Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11", "Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1", "Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL", "Adult Acute Myeloid Leukemia Without Maturation", "Adult Acute Myelomonocytic Leukemia", "Adult Erythroleukemia", "Adult Pure Erythroid Leukemia", "Alkylating Agent-Related Acute Myeloid Leukemia", "Recurrent Adult Acute Myeloid Leukemia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2016-09-01"
protocolSection.identificationModule.nctId
"NCT01870596"
protocolSection.identificationModule.officialTitle
"Randomized Phase II Trial of Timed Sequential Cytosine Arabinoside (Ara-C) With and Without the Checkpoint Kinase 1 (CHK1) Inhibitor MK-8776 in Adults With Relapsed AML"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2016-09-01"

Study condition terms

  • Adult Acute Megakaryoblastic Leukemia (protocolSection.conditionsModule.conditions)
  • Adult Acute Monoblastic Leukemia (protocolSection.conditionsModule.conditions)
  • Adult Acute Monocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 (protocolSection.conditionsModule.conditions)
  • Adult Acute Myeloid Leukemia With Maturation (protocolSection.conditionsModule.conditions)
  • Adult Acute Myeloid Leukemia With Minimal Differentiation (protocolSection.conditionsModule.conditions)
  • Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11 (protocolSection.conditionsModule.conditions)
  • Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1 (protocolSection.conditionsModule.conditions)
  • Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL (protocolSection.conditionsModule.conditions)
  • Adult Acute Myeloid Leukemia Without Maturation (protocolSection.conditionsModule.conditions)
  • Adult Acute Myelomonocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Adult Erythroleukemia (protocolSection.conditionsModule.conditions)
  • Adult Pure Erythroid Leukemia (protocolSection.conditionsModule.conditions)
  • Alkylating Agent-Related Acute Myeloid Leukemia (protocolSection.conditionsModule.conditions)
  • Recurrent Adult Acute Myeloid Leukemia (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.